In the middle cerebral artery occlusion (MCAO) model in vivo and the oxygen–glucose deprivation/re-oxygenation (OGD/R) cellular model in vitro, blocking the RIPK1/RIPK3/MLKL pathway could effectively alleviate ischemic stroke injuries [15, 30]. Here, MLKL is linked to ischemic stroke.